Journal of Neural Transmission

, Volume 115, Issue 3, pp 521–530 | Cite as

The anthraquinone derivative Emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia



Abnormality in cytokine signaling is implicated in the neuropathology of schizophrenia. Previously, we established an animal model for schizophrenia by administering epidermal growth factor (EGF) to neonatal rats. Here we investigated effects of the anthraquinone derivatives emodin (3-methyl-1,6,8-trihydroxyanthraquinone) and sennoside (bis-[d-glucopyranosyl-oxy]-tetrahydro-4,4′-dihydroxy-dioxo[bianthracene]-2,2′-dicarboxylic acid) on behaviors of this model and EGF signaling. Subchronic oral administration of emodin (50 mg/kg) suppressed acoustic startle responses and abolished prepulse inhibition (PPI) deficits in this rodent model. ANCOVA revealed that emodin had distinct effects on PPI and startle responses. In contrast, sennoside (50 mg/kg) had no effects. Emodin attenuated weight gain initially during treatment but had no apparent effect on weight gain and locomotor activity thereafter. Application of emodin to neocortical cultures attenuated the phosphorylation of ErbB1 and ErbB2. We conclude that emodin can both attenuate EGF receptor signaling and ameliorate behavioral deficits. Therefore, emodin might be a novel class of a pro-drug for anti-psychotic medication.

Keywords: Antipsychotic; behavior; inflammation; ErbB; EGF; schizophrenia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackerman, WE, Rovin, BH, Kniss, DA 2004Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cellsBiol Reprod7120792086PubMedCrossRefGoogle Scholar
  2. Anttila, S, Illi, A, Kampman, O, Mattila, KM, Lehtimaki, T, Leinonen, E 2004Association of EGF polymorphism with schizophrenia in Finnish menNeuroreport1512151218PubMedCrossRefGoogle Scholar
  3. Cadenhead, KS, Geyer, MA, Braff, DL 1993Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorderAm J Psychiatry15018621867PubMedGoogle Scholar
  4. Futamura, T, Toyooka, K, Iritani, S, Niizato, K, Nakamura, R, Tsuchiya, K, Someya, T, Kakita, A, Takahashi, H, Nawa, H 2002Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patientsMol Psychiatry7673682PubMedCrossRefGoogle Scholar
  5. Futamura, T, Kakita, A, Tohmi, M, Sotoyama, H, Takahashi, H, Nawa, H 2003Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive developmentMol Psychiatry81929PubMedCrossRefGoogle Scholar
  6. Gu, JW, Hasuo, H, Takeya, M, Akasu, T 2005Effects of emodin on synaptic transmission in rat hippocampal CA1 pyramidal neurons in vitroNeuropharmacology49103111PubMedCrossRefGoogle Scholar
  7. Hanninen, K, Katila, H, Anttila, S, Rontu, R, Maaskola, J, Hurme, M, Lehtimaki, T 2007Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patientsJ Psychiatry Res41814CrossRefGoogle Scholar
  8. Huang, Q, Lu, G, Shen, HM, Chung, MC, Ong, CN 2007Anti-cancer properties of anthraquinones from RhubarbMed Res Rev27609630PubMedCrossRefGoogle Scholar
  9. Iwakura, Y, Piao, YS, Mizuno, M, Takei, N, Kakita, A, Takahashi, H, Nawa, H 2005Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson’s disease and its model: neurotrophic implication in nigrostriatal neuronsJ Neurochem93974983PubMedCrossRefGoogle Scholar
  10. Jayasuriya, H, Koonchanok, NM, Geahlen, RL, McLaughlin, JL, Chang, CJ 1992Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatumJ Nat Prod55696698PubMedCrossRefGoogle Scholar
  11. Jahnke, GD, Price, CJ, Marr, MC, Myers, CB, George, JD 2004Developmental toxicity evaluation of emodin in rats and miceBirth Defects Res B Dev Reprod Toxicol7189101PubMedCrossRefGoogle Scholar
  12. Kaneshiro, T, Morioka, T, Inamine, M, Kinjo, T, Arakaki, J, Chiba, I, Sunagawa, N, Suzui, M, Yoshimi, N 2006Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylationEur J Pharmacol5534653PubMedCrossRefGoogle Scholar
  13. Kaszkin-Bettag, M, Ventskovskiy, BM, Kravchenko, A, Rettenberger, R, Richardson, A, Heger, PW, Heger, M 2007The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal womenMenopause14270283PubMedCrossRefGoogle Scholar
  14. Kumar, A, Dhawan, S, Aggarwal, BB 1998Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cellsOncogene17913918PubMedCrossRefGoogle Scholar
  15. Lee, HZ 2003Effects and mechanisms of emodin on cell death in human lung squamous cell carcinomaBr J Pharmacol1341120CrossRefGoogle Scholar
  16. Leng-Peschlow, E 1993Sennoside-induced secretion is not caused by changes in mucosal permeability or Na+,K(+)-ATPase activityJ Pharm Pharmacol45951954PubMedGoogle Scholar
  17. Li, HL, Chen, HL, Li, H, Zhang, KL, Chen, XY, Wang, XW, Kong, QY, Liu, J 2005Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophagesInt J Mol Med164147PubMedCrossRefGoogle Scholar
  18. Lu, MC, Hsieh, MT, Wu, CR, Cheng, HY, Hsieh, CC, Lin, YT, Peng, W 2007Ameliorating effect of emodin, a constitute of Polygonatum multiflorum, on cycloheximide-induced impairment of memory consolidation in ratsJ Ethnopharmacol112552556PubMedCrossRefGoogle Scholar
  19. Mizuno, M, Malta, RS,Jr, Nagano, T, Nawa, H 2004Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal periodAnn NY Acad Sci1025612618PubMedCrossRefGoogle Scholar
  20. Muller, N, Riedel, M, Ackenheil, M, Schwarz, MJ 2000Cellular and humoral immune system in schizophrenia: a conceptual re-evaluationWorld J Biol Psychiatry1173179PubMedCrossRefGoogle Scholar
  21. Muto, A, Hori, M, Sasaki, Y, Saitoh, A, Yasuda, I, Maekawa, T, Uchida, T, Asakura, K, Nakazato, T, Kaneda, T, Kizaki, M, Ikeda, Y, Yoshida, T 2007Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitorMol Cancer Ther6987994PubMedCrossRefGoogle Scholar
  22. Nakajima, K, Yamauchi, K, Kuwano, S 1985Isolation of a new aloe-emodin dianthrone diglucoside from senna and its potentiating effect on the purgative activity of sennoside A in miceJ Pharm Pharmacol37703706PubMedGoogle Scholar
  23. Nawa, H, Takei, N 2006Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokinesNeurosci Res56213PubMedCrossRefGoogle Scholar
  24. Nawa H, Mizuno M (2006) Antipsychotic molecular targeting epidermal growth factor. US patent application 20060167026Google Scholar
  25. Seroogy, KB, Numan, S, Gall, CM, Lee, DC, Kornblum, HI 1994Expression of EGF receptor mRNA in rat nigrostriatal systemNeuroreport6105108PubMedCrossRefGoogle Scholar
  26. Slice, LW, Chiu, T, Rozengurt, E 2005Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathwaysJ Biol Chem28015821593PubMedCrossRefGoogle Scholar
  27. Su, YT, Chang, HL, Shyue, SK, Hsu, SL 2005Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathwayBiochem Pharmacol70229241PubMedCrossRefGoogle Scholar
  28. Swerdlow, NR, Geyer, MA 1998Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophreniaSchizophr Bull24285301PubMedGoogle Scholar
  29. Swerdlow, NR, Geyer, MA, Braff, DL 2001Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challengesPsychopharmacology (Berlin)156194215CrossRefGoogle Scholar
  30. Takei, N, Inamura, N, Kawamura, M, Namba, H, Hara, K, Yonezawa, K, Nawa, H 2004Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendritesJ Neurosci2497609769PubMedCrossRefGoogle Scholar
  31. Tohmi, M, Tsuda, N, Mizuno, M, Takei, N, Frankland, PW, Nawa, H 2005Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strainsBehav Genet35615629PubMedCrossRefGoogle Scholar
  32. Wang, J, Huang, H, Liu, P, Tang, F, Qin, J, Huang, W, Chen, F, Guo, F, Liu, W, Yang, B 2006Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic ratsEur J Pharmacol553297303PubMedCrossRefGoogle Scholar
  33. Wang, R, Wan, Q, Zhang, Y, Huang, F, Yu, K, Xu, D, Wang, Q, Sun, J 2007Emodin suppresses interleukin-1beta induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPKLife Sci8024812488PubMedCrossRefGoogle Scholar
  34. Wang, SC, Zhang, L, Hortobagyi, GN, Hung, MC 2001Targeting HER2: recent developments and future directions for breast cancer patientsSemin Oncol62129CrossRefGoogle Scholar
  35. Yamauchi, K, Yagi, T, Kuwano, S 1993Suppression of the purgative action of rhein anthrone, the active metabolite of sennosides A and B, by calcium channel blockers, calmodulin antagonists and indomethacinPharmacology Suppl12231Google Scholar
  36. Zhang, L, Lau, YK, Xi, L, Hong, RL, Kim, DS, Chen, CF, Hortobagyi, GN, Chang, C, Hung, MC 1998Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated propertiesOncogene1628552863PubMedCrossRefGoogle Scholar
  37. Zhang, L, Lau, YK, Xia, W, Hortobagyi, GN, Hung, MC 1999Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxelClin Cancer Res5343353PubMedGoogle Scholar
  38. Zhu, YZ, Kang, B, Zhu, QQ 1996Clinical study of shuizhi-dahuang mixture in treating schizophrenics with blood stasis syndromeZhongguo Zhong Xi Yi Jie He Za Zhi16646648PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Center for Transdisciplinary ResearchNiigata UniversityNiigataJapan
  2. 2.Department of Molecular Neurobiology, Brain Research InstituteNiigata UniversityNiigataJapan

Personalised recommendations